Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02892708 : Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over
PhasePhase 3
AgesMin: 70 Years Max: N/A
Eligibility
Inclusion Criteria:

- Highly suggestive radiological aspect of a high-grade glioma

- Operability of the lesion, defined according to standard criteria of literature: lobar
tumor, cortico-subcortical, well limited, without deep infiltration and without
involvement of the basal ganglia. This operability is to reassess based on surgical
experience and the ability to remove more or less completely a tumor of this type in a
given location

- Age greater than or equal to 70 years

- Preoperative Karnofsky Index ? 50

- Information given to the patient or his family and signed written consent.

Exclusion Criteria:

- Existence of a cons-indication to MRI

- Non operability of the lesion

- Unbalanced concomitant serious pathology that might be an indication against-formal
anesthetic (ASA 4-5) (see annex)

- Previous history of radiotherapy or chemotherapy prior to this injury

- Patient under guardianship or under judicial protection
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02892708      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740